Yann Echelard insider trades
Open-market stock purchases and sales by Yann Echelard, Director at TG Therapeutics, Inc, from SEC Form 4 filings since Mar 15, 2013.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +285%.
Companies traded
- TGTX TG Therapeutics, Inc: 1 buy, 4 sales, last Jun 11, 2026